Zoster-related postherpetic neuralgia – burning sensation - Causes, Treatment & When to See a Doctor

```html

What is Zoster‑related postherpetic neuralgia – burning sensation?

Postherpetic neuralgia (PHN) is a chronic nerve‑pain condition that can linger for months or even years after a shingles (herpes zoster) infection has healed. The most common description of the pain is a “burning” sensation that may feel like hot coals, electric shocks, or a constant sting. PHN occurs because the varicella‑zoster virus, which lies dormant in dorsal‑root ganglia after a chicken‑pox infection, reactivates and damages sensory nerve fibers during the acute shingles rash. When the nerve injury does not fully recover, abnormal pain signals continue to be transmitted, manifesting as the characteristic burning pain of PHN.

According to the Mayo Clinic, up to 20 % of people who develop shingles will experience PHN, and the risk rises sharply after the age of 60. Although the pain is usually localized to the dermatome (skin area) where the rash appeared, it can spread or become more diffuse over time.

Common Causes

While the primary trigger for PHN is a resolved shingles outbreak, several factors increase the likelihood of developing a burning‑type neuralgia:

• Age ≥ 60 years – aging nerves heal more slowly.
• Severe acute shingles rash – extensive vesicles or prolonged lesions.
• Delayed antiviral therapy – starting antivirals >72 hours after rash onset.
• Immunosuppression – HIV, organ‑transplant meds, chemotherapy.
• Chronic diseases – diabetes mellitus, peripheral vascular disease.
• Painful or persistent nerve inflammation – e.g., herpes zoster ophthalmicus.
• Previous episodes of shingles – cumulative nerve damage.
• Smoking – impairs microvascular blood flow to nerves.
• Stress or depression – can amplify pain perception.
• Genetic predisposition – certain HLA types linked to higher PHN risk.

Associated Symptoms

Burning PHN rarely occurs in isolation. Patients often report a cluster of sensory disturbances:

• Allodynia: Pain from light touch (e.g., clothing, a gentle breeze).
• Hyperesthesia: Heightened sensitivity to temperature or pressure.
• Electric‑shock–like attacks (sharp, brief pains).
• Itching or tingling (paresthesia) in the same dermatome.
• Pain worsening at night, leading to sleep disruption.
• Skin changes – discoloration, dryness, or occasional secondary infection from scratching.
• Emotional symptoms – anxiety, irritability, or depression secondary to chronic pain.
• Fatigue from disrupted sleep and ongoing stress.

When to See a Doctor

Prompt medical attention can limit the duration and severity of PHN. Seek care if you notice any of the following:

• Burning pain that persists > 4 weeks after the shingles rash has crusted.
• Severe pain that interferes with daily activities or sleep.
• New or worsening skin lesions, especially if they become oozing, red, or foul‑smelling.
• Signs of infection (fever, chills, swollen lymph nodes).
• Development of visual symptoms (if the rash was near the eye).
• Any neurologic change such as weakness, facial droop, or difficulty moving the affected area.

Older adults, immunocompromised individuals, and people with diabetes should contact a healthcare provider sooner rather than later.

Diagnosis

Diagnosing PHN is primarily clinical, based on a history of shingles followed by persistent neuropathic pain. The evaluation typically includes:

1. Detailed History

• Date of rash onset and duration of lesions.
• Location of rash (dermatome) and pattern of pain.
• Previous antiviral use, vaccination status, and comorbidities.

2. Physical Examination

• Inspection of the healed rash area for residual erythema or scarring.
• Testing for allodynia with light touch (e.g., cotton swab).
• Neurologic exam to rule out motor deficits.

3. Diagnostic Tools (when needed)

• Quantitative Sensory Testing (QST): Measures temperature and pressure thresholds.
• Skin biopsy for small‑fiber neuropathy (rarely required).
• Blood tests to assess immune status or rule out other infections.
• Imaging (MRI/CT) only if there is suspicion of central nervous system involvement.

Treatment Options

Treatment aims to reduce pain, improve function, and prevent complications. A multimodal approach—combining medication, topical agents, and self‑care strategies—offers the best results.

Pharmacologic Therapies

• Antiviral agents (acyclovir, valacyclovir, famciclovir) – best started within 72 hours of rash; they may modestly reduce PHN risk.
• TCAs (Tricyclic Antidepressants) – amitriptyline or nortriptyline 10‑75 mg nightly; useful for burning pain.
• SNRIs (Serotonin‑Norepinephrine Reuptake Inhibitors) – duloxetine or venlafaxine, especially in patients with comorbid depression.
• Anticonvulsants – gabapentin (300‑1200 mg/day) or pregabalin (75‑300 mg/day) are first‑line for neuropathic pain.
• Topical agents
  • Lidocaine 5 % patches applied to the painful area for 12 hours on/12 hours off.
  • Capsaicin 0.075 % cream (3‑4 times daily) or high‑dose 8 % patch (single application lasting up to 3 months).
• Opioids – Generally discouraged due to dependence risk; may be considered short‑term for severe refractory pain under strict monitoring.
• Steroid injections – Occasionally used for localized allodynia, but evidence is limited.

Non‑Pharmacologic Therapies

• Cold or warm compresses – Gentle application can modulate burning sensations.
• Transcutaneous Electrical Nerve Stimulation (TENS) – May reduce pain intensity.
• Physical therapy – Gentle range‑of‑motion exercises to prevent muscle stiffness.
• Cognitive‑behavioral therapy (CBT) – Helps patients cope with chronic pain and associated mood changes.
• Acupuncture – Some studies show modest benefit for neuropathic pain.
• Sleep hygiene – Dark, cool bedroom, limiting caffeine, and using relaxation techniques.

Self‑Care Measures

• Keep the affected skin clean and moisturized to avoid secondary infection.
• Avoid tight clothing or fabrics that may irritate the area.
• Use mild, fragrance‑free soaps and lukewarm water.
• Maintain a balanced diet rich in B‑vitamins, omega‑3 fatty acids, and antioxidants.
• Stay hydrated; dehydration can worsen neuropathic sensations.

Prevention Tips

Because PHN follows shingles, preventing the initial varicella‑zoster reactivation is the most effective strategy.

• Shingles vaccine (Shingrix) – Recombinant subunit vaccine approved for adults ≥ 50 years; > 90 % efficacy in reducing shingles and PHN (CDC).
• Early antiviral therapy – Start within 72 hours of rash onset; reduces viral replication and nerve damage.
• Maintain a healthy immune system – Regular exercise, adequate sleep, stress management, and a balanced diet.
• Control chronic illnesses – Tight glycemic control in diabetes, blood pressure management, and smoking cessation.
• Prompt treatment of acute shingles – Follow up with healthcare providers if the rash is extensive or involves the face/eye.

Emergency Warning Signs

Key Take‑aways

Postherpetic neuralgia with a burning sensation is a painful sequela of shingles that can persist for months or years. Early antiviral treatment, vaccination, and a multimodal pain‑management plan are essential to reduce its impact. If the pain is persistent, worsening, or accompanied by concerning skin or neurologic changes, contact a healthcare professional promptly. Reliable information from sources such as the CDC, NIH, and the Cleveland Clinic can guide patients in making informed decisions.

```